Hepatocyte growth factor stimulated renal tubular mitogenesis: Effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes

British Journal of Cancer

Volumn 77, Issue 9, 1998, Pages 1420-1428

  Clifford, S C ^a,b   Czapla, K ^c   Richards, F M ^a,b   O'Donoghue, D J ^c   Maher, E R ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

c myc; Elongin; Hepatocyte growth factor; Mitogenesis; Renal tubule; Vascular endothelial growth factor; VHL

Indexed keywords

SCATTER FACTOR; VASCULOTROPIN;

ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY TUBULE; MITOGENESIS; NORMAL HUMAN; ONCOGENE; ONCOGENE C FOS; ONCOGENE C MET; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031953336     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.235     Document Type: Article

References (51)

1. Aso T, Lune WS, Conaway JW and Conaway RC (1995) Elongin (SIII) - a multisubunit regulator of elongation by RNA polymerase II. Science 269: 1439-1443
2. Boccaccio C, Gaudino G, Gambarotta G, Galimi F and Comoglio PM (1994) Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed early response to HGF. J Biol Chem 269: 12846-12851
3. Breier G, Albrecht U, Sterrer S and Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532
4. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF and Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262
5. Cantley LG, Barros EJG, Gandhi M, Rauchman M and Nigam SK (1994) Regulation of mitogenesis, motogenesis and tubulogenesis by hepatocyte growth-factor in renal collecting duct cells. Am J Physiol 267: F271-F280
6. Chang HG, Okuda T, Nomura Y, Nagao T, Nakamura T, Kurokawa K and Katoh T (1996) Serum hepatocyte growth-factor concentration in patients with various degrees of chronic-renal-failure. Nephrology 2: 175-179
7. Chen F, Kishida T, Duh F-M, Renbaum P, Orcutt ML, Schmidt L and Zbar B (1995) Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res 55: 4804-4807
8. Clifford SC, Thomas DJ, Neal DE and Lunec J (1994) Increased MDR1 gene transcript levels in high grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer 69: 680-686
9. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Elfino JJ, Siegel NR, Leimgruber RM and Feder J (1989) Tumor vascular-permeability factor stimulates endothelial-cell growth and angiogenesis. J Clin Invest 84: 1470-1478
10. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS and Sens DA (1984) Tissue-culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25: 383-390
11. Dressler GR and Douglass EC (1992) Pax-2 is a DNA binding protein expressed in embryonic kidney and Wilms' tumour. Proc Natl Acad Sci USA 89: 1179-1183
12. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garret KP, Conaway RC, Conaway JW, Linehan WM and Klausner RD (1995) Inhibition of transcription elongation by the VHL tumour suppressor protein. Science 269: 1402-1407
13. Eick D, Polack A, Kofler E, Lenoir GM, Rickinson AB and Bornkamm GW (1990) Expression of P0 and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells. Oncogene 9: 1397-1402
14. Ferrara N, Houck KA, Jakeman LB, Winer J and Leung DW (1991) The vascular endothelial growth-factor family of polypeptides. J Cell Biochem 47: 211-218
15. Finkenzeller G, Technau A and Marme D (1995) Hypoxia-induced transcription of the vascular endothelial growth-factor gene is independent of functional ap-1 transcription factor. Biochem Biophys Res Commun 208: 432-439
16. Fleischmann J and Huntley NH (1994) Renal tumours. In Clinical Urology, Krane RJ, Siroky MB and Fitzpatrick JM. (eds), pp. 359-373. JB Lipincott: Philadelphia
17. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM and Maher ER (1994) Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma. Hum Mol Genet 3: 2169-2173
18. Gnarra JR and Dressler GR (1995) Expression of pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 55: 4092-4098
19. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B and Linehan WM (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet 7: 85-90
20. Gnarra JR, Zhou SB, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD and Linehan WM (1996) Posttranscriptional regulation of vascular endothelial growth-factor messenger-RNA by the product of the VHL tumor-suppressor gene. Proc Natl Acad Sci USA 93: 10589-10594
21. Grugel S, Finkenzeller G, Weindel K, Barleon B and Marme D (1995) Both v-Ha-Ras and v-raf stimulate expression of the vascular endothelial growth-factor in NIH 3T3 cells. J Biol Chem 270: 25915-25919
22. Harris RC, Burns KD, Alattar M, Homma T and Nakamura T (1993) Hepatocyte growth-factor stimulates phosphoinositide hydrolysis and mitogenesis in cultured renal epithelial-cells. Life Sci 52: 1091-1100
23. Herman JG, Latif F, Weng Y, Lerman MJ, Zbar B, Liu S, Samid D, Duan DR, Gnarra JR, Linehan WM and Baylin SB (1994) Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
24. Horikoshi T, Danenberg KD, Stadlbauer THW, Vlkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP and Danenberg PV (1992) Quantitation of thymidylate synthase dihydrofolate reductase and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52: 108-116
25. Ikeda E, Achen MG, Brier G and Risau W (1995) Hypoxia-induced transcriptional activation and increased messenger-RNA stability of vascular endothelial growth-factor in C6 glioma-cells. J Biol Chem 270: 19761-19766
26. Iliopoulos O, Kibel A, Gray S and Kaelin Jr WG (1995) Tumour suppression by the human von Hippel-Lindau gene product. Nature 1: 822-826
27. Iliopoulos O, Levy AP, Jiang C, Kaelin WG and Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599
28. Johnson M, Kochhar K, Nakamura T and Iyer A (1995) Hepatocyte growth factor-induced signal transduction in two normal mouse epithelial cell lines. Biochem Mol Biol Int 36: 465-474
29. Kawaida K, Matsumoto K, Shimazu H and Nakamura T (1994) Hepatocyte growth-factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91: 4357-4361
30. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J and Connolly DT (1989) Vascular-permeability factor: an endothelial-cell mitogen related to PDGF. Science 246: 1309-1312
31. Kibel A, Iliopoulos O, DeCaprio JA and Kaelin WG (1995) Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269: 1444-1446
32. Kohlhuber F. Strobl LJ and Eick D (1993) Early down-regulation of c-myc in dimethylsulfoxide-induced mouse erythroleukemia (mel) cells is mediated at the P1/P2 promoters. Oncogene 8: 1099-1102
33. Krumm A, Meulia T, Brunvand M and Groudine M (1992) The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev 6: 2201-2213
34. Kuzmin I, Duh F-M, Latif F, Geil L, Zbar B and Lerman MI(1995) Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 10: 2185-2194
35. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutl ML, Stackhouse T, Kuzmin I, Mosi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B and Lerman MI (1993) Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 260: 1317-1320
36. Lee S, Chen DYT, Humphrey JS, Gnarra JR, Linehan WM and Klausner RD (1996) Nuclear-cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell-density. Proc Natl Acad Sci USA 93: 1770-1775
37. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N (1989) Vascular endothelial growth-factor is a secreted angiogenic. Science 246: 1306-1309
38. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R and Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77: 1151-1163
39. Pause A, Lee S, Worrell RA, Chen DYT, Burgess WH, Linehan WM and Klausner RD (1997) The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2 a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94: 2156-2161
40. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T and Kerbel RS (1995) Mutant ras oncogenes up-regulate VEGF/VPF expression - implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580
41. Richards FM, Schofield PN, Fleming S and Maher ER (1996) Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Hum Mol Genet 5: 639-644
42. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Richard S, Lips CJM, McCellan MW, Lap-Chee T, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Lerman MI, Linehan WM and Zbar B (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet 16: 68-73
43. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI and Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852-2855
44. Siemeister G, Weindel K, Mohrs K, Barleton B, Martiny-Baron G and Marme D (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel Lindau tumour suppressor protein. Cancer Res 56: 2299-2301
45. Silvagno F, Follenzi A, Arese M, Prat M, Giraudo E, Gaudino G, Camussi G, Comoglio PM and Bussolino F (1995) In-vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth-factor molecule promotes angiogenesis. Arter Thromb Vasc Biol 15: 1857-1865
46. Spencer CA and Groudine M (1991) Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 56: 1-48
47. Stackhouse TM, Kishida T, Chase D, Ferris DK, Kuzmin I, Geil L, Orcutt ML, Sakashita N, Takeya M, Renbaum P and Zbar B (1996) Phosphorylation of the von Hippel-Lindau disease tumour suppressor protein by casein kinase II. (in press)
48. Strobl LJ and Eick D (1992) Hold back of RNA polymerase-II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J 11: 3307-3331
49. Wizigmann-Voos S, Breier G, Risau W and Plate KH (1995) Up-regulation of vascular endothelial growth factor and its receptor in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358-1364
50. Woolf AS, Kolatsijoannou M, Hardman P, Andermarcher E, Moorby C, Fine LG, Jat PS, Noble MD and Gherardi E (1995) Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol 128: 171-184
51. Yao M, Shuin T, Misaki H and Kubota Y (1988) Enhanced expression of e-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res 48: 6753-6757